Department of Neurosurgery, Health Sciences University, Ümraniye Training and Research Hospital, İstanbul, Turkey.
Clinic of Neurosurgery, Sivas State Hospital, Sivas, Turkey.
Acta Orthop Traumatol Turc. 2022 Jul;56(4):268-271. doi: 10.5152/j.aott.2022.22035.
The aim of this study was to report the results of percutaneous vertebroplasty in managing symptomatic osteolytic cervical spine tumors.
This study comprised a retrospective examination of patients who received percutaneous vertebroplasty between 2008 and 2020 for the treatment of tumor-induced symptomatic cervical vertebra involvement. The study summarized the demographics, vertebral levels, pain control rates, clinical results, and complications of percutaneous vertebroplasty using an anterolateral approach.
The study sample consisted of 6 female and 2 male patients aged between 20 and 56 (mean=41.37) years. Tumors were located at C2 in 6 cases, at C3 in 1 case, and at C5 in another. The mean volume of poly (methyl methacrylate) injected was 1.5 mL (range: 1-2 mL). Biopsy results showed the presence of metastasis in 5 cases and plasmacytoma in 3. No postoperative complications or mortality were observed after the procedure. Preoperative mean 7.75 visual analog scale score decreased to 2.62. Pain control was reported to be 66.2%.
Anterolateral cervical vertebroplasty seems to be a safe, effective, and helpful therapeutic alternative for the treatment of cervical spine tumors. It reduces the risk of infection compared to the transoral method.
Level IV, Therapeutic Study.
本研究旨在报告经皮椎体成形术治疗溶骨性颈椎肿瘤所致症状性病变的结果。
本研究回顾性分析了 2008 年至 2020 年间因肿瘤引起的颈椎病变而接受经皮椎体成形术治疗的患者。本研究总结了经前路入路治疗肿瘤诱导的症状性颈椎受累的患者的人口统计学、椎体水平、疼痛控制率、临床结果和并发症。
研究样本包括 6 名女性和 2 名男性，年龄 20 至 56 岁（平均 41.37 岁）。肿瘤位于 C2 椎体 6 例，C3 椎体 1 例，C5 椎体 1 例。注射的聚甲基丙烯酸甲酯的平均体积为 1.5 毫升（范围：1-2 毫升）。活检结果显示 5 例存在转移，3 例为浆细胞瘤。术后无并发症或死亡。术前平均视觉模拟评分（VAS）为 7.75 分，术后降至 2.62 分。疼痛控制率为 66.2%。
经前路颈椎椎体成形术似乎是治疗颈椎肿瘤的一种安全、有效、有益的治疗选择。与经口方法相比，它降低了感染的风险。
IV 级，治疗性研究。
